Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

If ending AIDS by 2030 remains our promise, defending UNAIDS is defending life itself. Governments, donors, and civil society must stand firm so no one is left behind. Thank you for reading ...

South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...

One public health expert described Fiji as a gateway country to other Pacific Islands, warning that, "We could see an ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Caught between withdrawn donor funding and a rocky Social Health Authority rollout, Kenyans living with HIV are now forced to ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

A new report by the Global Council on Inequality, AIDS and Pandemics, will be launched on 3 November in Johannesburg - and worldwide online - showing the danger of inequalities that are prolonging ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...